{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:29:49Z","timestamp":1788654589972,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.xphs.2021.11.007","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:20:15Z","timestamp":1637356815000},"page":"794-809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Harnessing of Doxylamine Succinate\/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal"],"prefix":"10.1016","volume":"111","author":[{"given":"Heba F.","family":"Salem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7288-0030","authenticated-orcid":false,"given":"Amira M.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Rahman A.","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba M.","family":"Aboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.xphs.2021.11.007_bib0001","first-page":"965","article-title":"Nausea and vomiting of pregnancy","volume":"89","author":"Herrell","year":"2014","journal-title":"Am Fam Physician"},{"issue":"7","key":"10.1016\/j.xphs.2021.11.007_bib0002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/jcph.480","article-title":"Comparing pyridoxine and doxylamine succinate-pyridoxine HCl for nausea and vomiting of pregnancy: a matched, controlled cohort study","volume":"55","author":"Pope","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.xphs.2021.11.007_bib0003","first-page":"809787","article-title":"Preemptive treatment of nausea and vomiting of pregnancy: results of a randomized controlled trial","volume":"2013","author":"Maltepe","year":"2013","journal-title":"Obstetr Gynecol Int"},{"issue":"5","key":"10.1016\/j.xphs.2021.11.007_bib0004","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1067\/mob.2002.122592","article-title":"Nausea and vomiting of pregnancy: an obstetric syndrome","volume":"186","author":"Goodwin","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.xphs.2021.11.007_bib0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00006250-200404000-00045","article-title":"ACOG practice bulletin: nausea and vomiting of pregnancy","volume":"103","author":"Obstetricians","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.xphs.2021.11.007_bib0006","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejps.2018.07.059","article-title":"Chemical cross-linking: a feasible approach to prolong doxylamine\/pyridoxine release from spray-dried chitosan microspheres","volume":"123","author":"Katsarov","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2021.11.007_bib0007","unstructured":"Plakogiannis FM, McAfee D, Lather T, et\u00a0al. Transdermal Delivery of Doxylamine Succinate and Pyridoxine Hydrochloride. 2018, Google Patents."},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2014.03.004","article-title":"Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules","volume":"88","author":"Fortuna","year":"2014","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2021.11.007_bib0009","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jddst.2018.10.027","article-title":"Intranasal optimized solid lipid nanoparticles loaded in situ gel for enhancing trans-mucosal delivery of simvastatin","volume":"48","author":"Ahmed","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart materials: in situ gel-forming systems for nasal delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discov Today"},{"issue":"13","key":"10.1016\/j.xphs.2021.11.007_bib0011","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.3390\/molecules25132959","article-title":"Phospholipid vesicles for dermal\/transdermal and nasal administration of active molecules: the effect of surfactants and alcohols on the fluidity of their lipid bilayers and penetration enhancement properties","volume":"25","author":"Natsheh","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.xphs.2021.11.007_bib0012","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.3109\/10717544.2015.1013587","article-title":"Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation","volume":"23","author":"Aboud","year":"2016","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2021.11.007_bib0013","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08982104.2019.1610435","article-title":"Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation","volume":"30","author":"Khallaf","year":"2020","journal-title":"J Liposome Res"},{"issue":"20-22","key":"10.1016\/j.xphs.2021.11.007_bib0014","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/S0264-410X(00)00537-5","article-title":"Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)","volume":"19","author":"Conacher","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.xphs.2021.11.007_bib0015","first-page":"1847","article-title":"Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide\/protein-based therapeutics or vaccines","volume":"23","author":"Aburahma","year":"2016","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2021.11.007_bib0016","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.nano.2013.08.012","article-title":"Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration","volume":"10","author":"Jain","year":"2014","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"2b","key":"10.1016\/j.xphs.2021.11.007_bib0017","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1476-5381.2011.01452.x","article-title":"Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes","volume":"164","author":"Shukla","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.xphs.2021.11.007_bib0018","doi-asserted-by":"crossref","first-page":"9783","DOI":"10.2147\/IJN.S278688","article-title":"Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation","volume":"15","author":"Ahmed","year":"2020","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0019","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/08982104.2018.1430831","article-title":"Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study","volume":"29","author":"Aziz","year":"2019","journal-title":"J Liposome Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.11.007_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2015.03.033","article-title":"Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam","volume":"485","author":"Al-Mahallawi","year":"2015","journal-title":"Int J Pharm"},{"issue":"1-2","key":"10.1016\/j.xphs.2021.11.007_bib0021","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","article-title":"Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment","volume":"513","author":"Abdelbary","year":"2016","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2021.11.007_bib0022","first-page":"347","article-title":"Nasal drug delivery of sumatriptan succinate","volume":"60","author":"Chavanpatil","year":"2005","journal-title":"Die Pharmazie"},{"issue":"2","key":"10.1016\/j.xphs.2021.11.007_bib0023","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13346-019-00688-1","article-title":"A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation","volume":"10","author":"El Menshawe","year":"2020","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-153X-7-22","article-title":"Application of smart spectrophotometric methods and artificial neural network for the simultaneous quantitation of olmesartan medoxamil, amlodipine besylate and hydrochlorothiazide in their combined pharmaceutical dosage form","volume":"7","author":"Darwish","year":"2013","journal-title":"Chem Cent J"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0025","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/10717544.2019.1686087","article-title":"Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund\u2019s adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway","volume":"26","author":"El Menshawe","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2021.11.007_bib0026","article-title":"Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study","volume":"54","author":"Eid","year":"2019","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0027","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1080\/10717544.2018.1477858","article-title":"Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting","volume":"25","author":"Aboud","year":"2018","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2021.11.007_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2017.03.039","article-title":"Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats","volume":"254","author":"Mahmoud","year":"2017","journal-title":"J Control Release"},{"issue":"7","key":"10.1016\/j.xphs.2021.11.007_bib0029","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/03639040801926030","article-title":"Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels","volume":"34","author":"Mansour","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s13346-019-00676-5","article-title":"A novel transdermal nanoethosomal gel of lercanidipine HCl for treatment of hypertension: optimization using Box-Benkhen design, in vitro and in vivo characterization","volume":"10","author":"Salem","year":"2020","journal-title":"Drug Deliv Transl Res"},{"issue":"6","key":"10.1016\/j.xphs.2021.11.007_bib0031","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1208\/s12249-015-0440-8","article-title":"Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery","volume":"17","author":"Aboud","year":"2016","journal-title":"AAPS Pharmscitech"},{"key":"10.1016\/j.xphs.2021.11.007_bib0032","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"issue":"6","key":"10.1016\/j.xphs.2021.11.007_bib0033","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/bdd.314","article-title":"Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats","volume":"23","author":"Pelser","year":"2002","journal-title":"Biopharm Drug Dispos"},{"issue":"3","key":"10.1016\/j.xphs.2021.11.007_bib0034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.18433\/J3H89S","article-title":"Enhancement of skin penetration of hydrophilic and lipophilic compounds by pH-sensitive liposomes","volume":"18","author":"Tokudome","year":"2015","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.11.007_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0928-0987(01)00110-5","article-title":"A comparative study of an in situ adapted diffusion cell and an in vitro Franz diffusion cell method for transdermal absorption of doxylamine","volume":"13","author":"Venter","year":"2001","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0036","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/mp034006h","article-title":"Molecular properties of WHO essential drugs and provisional biopharmaceutical classification","volume":"1","author":"Kasim","year":"2004","journal-title":"Mol Pharm"},{"key":"10.1016\/j.xphs.2021.11.007_bib0037","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.2147\/IJN.S135749","article-title":"Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: Optimization, characterization, and evaluation in vitro and in vivo","volume":"12","author":"Zhang","year":"2017","journal-title":"Int J Nanomed"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10717544.2016.1247928","article-title":"Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies","volume":"24","author":"Abdelbary","year":"2017","journal-title":"Drug Deliv"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.11.007_bib0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2009.04.022","article-title":"Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt","volume":"376","author":"Chen","year":"2009","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2021.11.007_bib0040","first-page":"4331","article-title":"Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application","volume":"9","author":"Mahmood","year":"2014","journal-title":"Int J Nanomed"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.11.007_bib0041","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2013.11.028","article-title":"Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study","volume":"460","author":"Niu","year":"2014","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.xphs.2021.11.007_bib0042","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/08982104.2012.700460","article-title":"Brain delivery of olanzapine by intranasal administration of transfersomal vesicles","volume":"22","author":"Salama","year":"2012","journal-title":"J Liposome Res"},{"issue":"7","key":"10.1016\/j.xphs.2021.11.007_bib0043","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/02652040802055411","article-title":"Vesicular aceclofenac systems: a comparative study between liposomes and niosomes","volume":"25","author":"Nasr","year":"2008","journal-title":"J Microencapsul"},{"key":"10.1016\/j.xphs.2021.11.007_bib0044","article-title":"Bilosomes nanocarriers for improved oral bioavailability of acyclovir: a complete characterization through in vitro, ex-vivo and in vivo assessment","volume":"57","author":"Saifi","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2021.11.007_bib0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"El Zaafarany","year":"2010","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2021.11.007_bib0046","first-page":"283","article-title":"Development and characterization of nanoparticles of glibenclamide by solvent displacement method","volume":"67","author":"Dora","year":"2010","journal-title":"Acta Pol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0047","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00118-6","article-title":"Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future","volume":"47","author":"M\u00fcller","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2021.11.007_bib0048","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/10837450.2012.727001","article-title":"Effect of fixed aqueous layer thickness of polymeric stabilizers on zeta potential and stability of aripiprazole nanosuspensions","volume":"18","author":"Abdelbary","year":"2013","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"10.1016\/j.xphs.2021.11.007_bib0049","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/jps.24315","article-title":"Phospholipid vesicle-based permeation assay and EpiSkin\u00ae in assessment of drug therapies destined for skin administration","volume":"104","author":"Engesland","year":"2015","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0050","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1080\/10717544.2020.1837295","article-title":"Ultra-deformable liposomes containing terpenes (terpesomes) loaded fenticonazole nitrate for treatment of vaginal candidiasis: Box-Behnken design optimization, comparative ex vivo and in vivo studies","volume":"27","author":"Albash","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2021.11.007_bib0051","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejps.2017.10.012","article-title":"Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats","volume":"111","author":"Ahad","year":"2018","journal-title":"Eur J Pharm Sci"},{"issue":"1-3","key":"10.1016\/j.xphs.2021.11.007_bib0052","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0927-7757(01)00733-6","article-title":"Surface conductivity of counter ions on protein-adsorbed lipid liposomes","volume":"192","author":"Matsumura","year":"2001","journal-title":"Colloids Surf A"},{"issue":"9","key":"10.1016\/j.xphs.2021.11.007_bib0053","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1080\/03639045.2017.1318907","article-title":"Optimization of methotrexate loaded niosomes by Box\u2013Behnken design: an understanding of solvent effect and formulation variability","volume":"43","author":"Zidan","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2021.11.007_bib0054","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","article-title":"Niosome-encapsulated gentamicin for ophthalmic controlled delivery","volume":"9","author":"Abdelbary","year":"2008","journal-title":"AAPS Pharmscitech"},{"issue":"12","key":"10.1016\/j.xphs.2021.11.007_bib0055","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1080\/03639045.2017.1361968","article-title":"Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes","volume":"43","author":"Mohsen","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"issue":"22","key":"10.1016\/j.xphs.2021.11.007_bib0056","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1021\/jp0219505","article-title":"Effect of cholesterol on the properties of phospholipid membranes. 1. Structural features","volume":"107","author":"Jedlovszky","year":"2003","journal-title":"J Phys Chem B"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08982104.2019.1577256","article-title":"Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay","volume":"30","author":"El-Nabarawi","year":"2020","journal-title":"J Liposome Res"},{"issue":"3","key":"10.1016\/j.xphs.2021.11.007_bib0058","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cej.2010.11.062","article-title":"Adsorption modeling of Cr, Cd and Cu on activated carbon of different origins by using fractional factorial design","volume":"166","author":"De Lima","year":"2011","journal-title":"Chem Eng J"},{"issue":"3\u20134","key":"10.1016\/j.xphs.2021.11.007_bib0059","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molcatb.2006.02.019","article-title":"Statistical optimization of medium components and growth conditions by response surface methodology to enhance lipase production by Aspergillus carneus","volume":"40","author":"Kaushik","year":"2006","journal-title":"J Mol Catal B"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jhazmat.2007.05.061","article-title":"Statistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putida","volume":"151","author":"Annadurai","year":"2008","journal-title":"J Hazard Mater"},{"issue":"11","key":"10.1016\/j.xphs.2021.11.007_bib0061","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1080\/03639045.2018.1504963","article-title":"Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box\u2013Behnken statistical design","volume":"44","author":"Salem","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.11.007_bib0062","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1208\/s12249-013-9921-9","article-title":"Thermally triggered mucoadhesive in situ gel of loratadine: \u03b2-cyclodextrin complex for nasal delivery","volume":"14","author":"Singh","year":"2013","journal-title":"AAPS PharmSciTech"},{"issue":"4\u20135","key":"10.1016\/j.xphs.2021.11.007_bib0063","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejps.2007.08.006","article-title":"Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties","volume":"32","author":"Zaki","year":"2007","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2021.11.007_bib0064","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1020134521778","article-title":"Liposome clearance","volume":"22","author":"Ishida","year":"2002","journal-title":"Biosci Rep"},{"key":"10.1016\/j.xphs.2021.11.007_bib0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.colsurfb.2012.05.010","article-title":"Phospholipid based colloidal poloxamer\u2013nanocubic vesicles for brain targeting via the nasal route","volume":"100","author":"Salama","year":"2012","journal-title":"Colloids Surf B"},{"issue":"3","key":"10.1016\/j.xphs.2021.11.007_bib0066","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1208\/pt070367","article-title":"Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan","volume":"7","author":"Majithiya","year":"2006","journal-title":"AAPS Pharmscitech"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921006134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:35:29Z","timestamp":1758360929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921006134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0022354921006134"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.11.007","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing of Doxylamine Succinate\/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}